The Role of Autophagy in Anti-Cancer and Health Promoting Effects of Cordycepin.
Yu-Ying ChenChun-Hsien ChenWei-Chen LinChih-Wei TungYung-Chia ChenShang-Hsun YangBu-Miin HuangRong-Jane ChenPublished in: Molecules (Basel, Switzerland) (2021)
Cordycepin is an adenosine derivative isolated from Cordyceps sinensis, which has been used as an herbal complementary and alternative medicine with various biological activities. The general anti-cancer mechanisms of cordycepin are regulated by the adenosine A3 receptor, epidermal growth factor receptor (EGFR), mitogen-activated protein kinases (MAPKs), and glycogen synthase kinase (GSK)-3β, leading to cell cycle arrest or apoptosis. Notably, cordycepin also induces autophagy to trigger cell death, inhibits tumor metastasis, and modulates the immune system. Since the dysregulation of autophagy is associated with cancers and neuron, immune, and kidney diseases, cordycepin is considered an alternative treatment because of the involvement of cordycepin in autophagic signaling. However, the profound mechanism of autophagy induction by cordycepin has never been reviewed in detail. Therefore, in this article, we reviewed the anti-cancer and health-promoting effects of cordycepin in the neurons, kidneys, and the immune system through diverse mechanisms, including autophagy induction. We also suggest that formulation changes for cordycepin could enhance its bioactivity and bioavailability and lower its toxicity for future applications. A comprehensive understanding of the autophagy mechanism would provide novel mechanistic insight into the anti-cancer and health-promoting effects of cordycepin.
Keyphrases
- cell death
- cell cycle arrest
- epidermal growth factor receptor
- endoplasmic reticulum stress
- oxidative stress
- signaling pathway
- public health
- healthcare
- tyrosine kinase
- mental health
- pi k akt
- health information
- advanced non small cell lung cancer
- spinal cord injury
- protein kinase
- drug delivery
- risk assessment
- young adults
- cell proliferation
- intellectual disability